lobbying_activities: 2307669
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2307669 | 5e61b84a-8855-4636-907c-75eaec60e71d | Q2 | KOUNTOUPES DENHAM CARR & REID, LLC | 320918 | GLENMARK PHARMACEUTICALS, INC., USA | 2019 | second_quarter | PHA | General information about the company and the industry. Issues related to affordability and pricing of pharmaceuticals. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2019-07-17T14:41:09.140000-04:00 |